An improved understanding of chronic graft-versus-host disease (cGVHD) and its pathogenesis has led to the development of novel treatments. Future ......READ MORE
patient care perspectives by Corey Cutler, MD, MPH, FRCPC
Chronic graft-versus-host disease (cGVHD) may have some atypical manifestations that have not classically been ascribed to the disease. Efforts to ......READ MORE
clinical topic updates by Corey Cutler, MD, MPH, FRCPC
Chronic graft-versus-host disease (cGVHD) involves both inflammatory and fibrotic pathologies. While most treatments for cGVHD target the inflammat......READ MORE
patient care perspectives by Michael C. Heinrich, MD
The risk of recurrence, growth, and spread of gastrointestinal stromal tumors (GIST) after surgery relates to key variables such as the size, locat......READ MORE
expert roundtables by Tanya B. Dorff, MD; Robert Dreicer, MD, MS, MACP, FASCO; and Neal D. Shore, MD, FACS
With multiple treatments now available for advanced prostate cancer, there are many options for the sequencing of therapies. Our featured experts e......READ MORE
expert roundtables by Tanya B. Dorff, MD; Robert Dreicer, MD, MS, MACP, FASCO; and Neal D. Shore, MD, FACS
Molecular and genomic tests have the potential to add key prognostic data to the assessment of earlier-stage prostate cancer. Ongoing trials seek t......READ MORE
Combination strategies have led to improved survival in patients with advanced prostate cancer. Researchers hope to build on this success by implem......READ MORE
